Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

Executive Summary

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

You may also be interested in...



USP Working Toward Medicare Formulary PBMs Can Use, McClellan Says

U.S. Pharmacopeia will make sure its model Medicare formulary guidelines "work" for prescription drug plan sponsors as it constructs the final version, Centers for Medicare & Medicaid Services Administrator Mark McClellan says

USP Working Toward Medicare Formulary PBMs Can Use, McClellan Says

U.S. Pharmacopeia will make sure its model Medicare formulary guidelines "work" for prescription drug plan sponsors as it constructs the final version, Centers for Medicare & Medicaid Services Administrator Mark McClellan says

Ketek, Allegra Deserve Special Formulary Status – Aventis Consultants

The ketolide drug class should be added to the U.S. Pharmacopeia's model drug classification system as a unique pharmacologic class, Stephen Jenkins, PhD, Carolinas Medical Center said during an Aug. 27 public meeting on the proposed Medicare Rx formulary guidelines

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044425

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel